Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 118 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Egilman AC, Zhang AD, Wallach JD, Ross JS. Medicare Part D spending on single-enantiomer drugs versus their racemic precursors . Ann Intern Med 2019:13 de agosto. [Ref.ID 103162]
2. Cita con resumen
McQuaid J. Asthma takes a hard toll on African-Americans. Can precision medicine ease the burden?. STAT Daily Recap 2019:26 de marzo. [Ref.ID 103064]
3. Cita con resumen
Fralick M, Avorn J, Kesselheim AS. The price of crossing the border for medications. N Engl J Med 2017;377:311-3. [Ref.ID 101925]
4. Cita con resumen
Greenway T, Ross JS. US drug marketing: how does promotion correspond with health value?. BMJ 2017;357:j1855. [Ref.ID 101571]
5.Enlace a cita original Cita con resumen
Page II RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J, On behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Trans- plantation Committees of the Council on Clini- cal Cardiology, Coun- cil on Cardiovascular Surgery and Anesthesia, Council on Cardio- vascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Drugs that may cause or exacerbate heart failure. A scientific statement from the American Heart Association. Circulation 2016;134:9 de agosto. [Ref.ID 100519]
6.
Thompson BT. ß-agonists for ARDS: the dark side of adrenergic stimulation?. Lancet 2012;379:196-8. [Ref.ID 92133]
7. Cita con resumen
Smith FG, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE, for the BALTI-2 study investigators. Effect of intravenous ß-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012;379:229-35. [Ref.ID 92132]
8. Cita con resumen
Wechsler ME, Kelley JM, Boyd IOE, Dutile S, Marigowda G, Kirsch I, Israel E, Kaptchuk TJ. Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med 2011;365:119-26. [Ref.ID 90832]
9. Cita con resumen
Anónimo. Resultados clínicos de medicamentos de marca frente a genéricos: una revisión actualizada a 28/02/11. Boletín Terapéutico Extremeño 2011;2:1-8. [Ref.ID 90001]
10.Tiene citas relacionadas
Lazarus SC. Emergency treatment of asthma. The author replies. N Engl J Med 2010;363:2568-9. [Ref.ID 89826]
11.Tiene citas relacionadas
Chi T, Sinert R. Emergency treatment of asthma. N Engl J Med 2010;363:2568. [Ref.ID 89825]
12.Tiene citas relacionadas
Franchini S, Marinosci A, Cicenia G. Emergency treatment of asthma. N Engl J Med 2010;363:2567. [Ref.ID 89824]
13.Enlace a cita originalTiene citas relacionadas Cita con resumen
Lazarus SC. Emergency treatment of asthma. N Engl J Med 2010;363:755-64. [Ref.ID 89152]
14.
Niewoehner DE. Outpatient management of severe COPD. N Engl J Med 2010;362:1407-16. [Ref.ID 88280]
15. Cita con resumen
Fanta CH. Asthma. N Engl J Med 2009;360:1002-14. [Ref.ID 85400]
16. Cita con resumen
Anónimo. Salbutamol: caries dentaires. Prescrire 2008;28:747. [Ref.ID 84255]
17. Cita con resumen
Grippi MA, Mulrow C. Trials that matter: minimizing treatment of mild, persistent asthma. Ann Intern Med 2007;147:344-5. [Ref.ID 81028]
18.
Townshend J, Hails S, Mckean M. Management of asthma in children. BMJ 2007;335:253-7. [Ref.ID 80754]
19. Cita con resumen
Sabaté M, Ibáñez L, Pérez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forné M, Solà R, Castellote J, Rigau J, Laporte JR. Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther 2007;25:1401-9. [Ref.ID 80401]
20.Tiene citas relacionadas Cita con resumen
Kraft M, Israel E, O'Connor GT. Treatment of mild persistent asthma. N Engl J Med 2007;356:2096-100. [Ref.ID 80047]
Seleccionar todas
 
 1 a 20 de 118 siguiente >>